Cyclerion Therapeutics, Inc.·4

Mar 27, 8:38 PM ET

Hecht Peter M 4

4 · Cyclerion Therapeutics, Inc. · Filed Mar 27, 2025

Insider Transaction Report

Form 4
Period: 2025-03-25
Hecht Peter M
Director10% Owner
Transactions
  • Award

    Common Stock

    2025-03-25$2.75/sh+181,818$500,000559,203 total
Holdings
  • Common Stock

    (indirect: By Trust)
    24
  • Common Stock

    (indirect: By Trust)
    24
  • Common Stock

    (indirect: By Trust)
    24
Footnotes (2)
  • [F1]On March 25, 2025, the reporting person purchased directly from the Issuer 181,818 shares of Common Stock for a total purchase price of approximately $500,000 (or $2.75 per share) in a private placement transaction pursuant to the Stock Purchase Agreement dated as of March 21, 2025 by and among the Issuer and the investors named therein.
  • [F2]These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4